CYFRPLSAT vs SOPHARMA

Side-by-side comparison of key ratios for CYFRPLSAT and SOPHARMA.

Last updated: Source: ESEF / GPW

MetricCYFRPLSAT CPSSOPHARMA SPH
P/E9.5
EPS (TTM)1.62
Dividend yield
Market cap8.46 mld6.77 mld

This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.

Methodology & data sources